Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis - C 2017 NCI 5F30CA180731-03 TCR Gene Transfer for Treating HCV-Associated Malignancies SPEAR, TIMOTHY LOYOLA UNIVERSITY CHICAGO IL $49,044
Hepatitis - C 2017 NIDA 5U01DA040381-02 Cohort Studies on HIV/AIDS and Substance Abuse in Miami BAUM, MARIANNA FLORIDA INTERNATIONAL UNIVERSITY FL $1,077,827
Hepatitis - C 2017 NIAID 5R01AI114748-03 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Hepatitis - C 2017 NIAID 5UM1AI069476-10 The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit GRINSZTEJN, BEATRIZ FUNDACAO OSWALDO CRUZ BRAZIL $74,365
Hepatitis - C 2017 NIDA 5R01DA035146-05 HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $550,788
Hepatitis - C 2017 NIMH 5K24MH097673-05 Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research LETENDRE, SCOTT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $182,619
Hepatitis - C 2017 NIAID 5R01AI103440-05 A molecular basis for control of T cell memory HEDRICK, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $465,000
Hepatitis - C 2017 NIDA 5P30DA011041-20 5121 Infectious Diseases and Biomedical Core PERLMAN, DAVID NEW YORK UNIVERSITY NY $145,226
Hepatitis - C 2017 NIAID 5R01AI110577-03 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $453,213
Hepatitis - C 2017 NIAID 5K08AI102761-05 Mechanisms of Neutralizing Antibody Resistance in Chronic HCV and HIV Infection BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $195,063
Hepatitis - C 2017 NIAID 5R01AI078881-07 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $531,399
Hepatitis - C 2017 NIAID 5R01AI108765-04 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $514,747
Hepatitis - C 2017 NIAID 5R01AI116943-02 A systematic analysis of small RNA interactions during RNA virus infections RICE, CHARLES ROCKEFELLER UNIVERSITY NY $545,126
Hepatitis - C 2017 NIAID 5R01AI085051-08 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $588,464
Hepatitis - C 2017 NIAID 5R37AI047365-18 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Hepatitis - C 2017 NIAID 5U01AI115714-03 Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant STOCK, PETER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $621,488
Hepatitis - C 2017 NCI 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $106,140
Hepatitis - C 2017 NIMHD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $209,615
Hepatitis - C 2017 NHLBI 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $286,781
Hepatitis - C 2017 NIAID 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $1,934,642
Hepatitis - C 2017 NICHD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $214,936
Hepatitis - C 2017 NIDA 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $53,072
Hepatitis - C 2017 NIDCD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $140,046
Hepatitis - C 2017 OD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $18,901
Hepatitis - C 2017 NIGMS 5R01GM116898-02 Function and mechanism of the HCV p7 channel and its therapeutic potential CHOU, JAMES HARVARD MEDICAL SCHOOL MA $463,975
Hepatitis - C 2017 NIDDK 5R01DK077704-09 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $337,125
Hepatitis - C 2017 NHLBI 5R01HL127174-02 Canonical & non-canonical regulation of the HDL receptor by PDZK1's PDZ domains KRIEGER, MONTY MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $494,995
Hepatitis - C 2017 NIAID 5K08AI121348-02 Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy MEISSNER, ERIC MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $199,314
Hepatitis - C 2017 NIAAA 5P50AA011999-19 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $206,355
Hepatitis - C 2017 NIDDK 5R01DK099055-04 Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease PARK, IN-WOO UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $333,558
Hepatitis - C 2017 NIAID 5R01AI113923-03 Positive Immune-regulators During Chronic Viral Infections ZUNIGA, ELINA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $459,066
Hepatitis - C 2017 NIAID 5R01AI105035-05 CD4+ T Cells in Acute Versus Chronic HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $435,000
Hepatitis - C 2017 NIAID 5R01AI116868-02 Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans RIBEIRO, RUY LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $835,913
Hepatitis - C 2017 NIAAA 5K23AA023753-03 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $199,800
Hepatitis - C 2017 NIDDK 5R01DK081817-07 HCV infection, cross-talk among liver cells, and liver disease progression RAY, RATNA SAINT LOUIS UNIVERSITY MO $340,875
Hepatitis - C 2017 NICHD 5R01HD075549-04 INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $321,437
Hepatitis - C 2017 NIAID 5R01AI106005-04 Dissecting virus neutralizing determinants to guide HCV vaccine development LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $457,124
Hepatitis - C 2017 NIAID 1R01AI127463-01 Mechanisms of hepatic innate immune activation by HCV GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $556,742
Hepatitis - C 2017 NIAID 5R01AI123365-02 Structure and function of Hepacivirus envelope glycoprotein LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $625,625
Hepatitis - C 2017 NIAID 5R01AI095690-07 Micro-RNA 122 and Chronic Hepatitis C LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $380,000
Hepatitis - C 2017 NIAID 5R01AI110358-03 Mechanisms of HCV Assembly YI, MINKYUNG UNIVERSITY OF TEXAS MED BR GALVESTON TX $387,500
Hepatitis - C 2017 NIDA 5R01DA027379-06 Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $485,246
Hepatitis - C 2017 NIDA 5R01DA016065-14 HCV Disease Management in HIV-HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $706,777
Hepatitis - C 2017 NIDA 5U01DA036935-04 HIV Disease Outcomes in Drug Users in Clinical Practice MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $1,496,559
Hepatitis - C 2017 NIDA 5R01DA012568-19 INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS MEHTA, SHRUTI JOHNS HOPKINS UNIVERSITY MD $1,213,726
Hepatitis - C 2017 NCI 1UG3CA211551-01 Field-deployable platform for prognostic hepatic cancer screening in low-resource settings PORTER, MARC UNIVERSITY OF UTAH UT $399,914
Hepatitis - C 2017 NIAID 1R21AI127924-01 Ferret cell determinants of hepatitis C virus tropism EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $253,347
Hepatitis - C 2017 NIAID 5R21AI119499-02 Hepatitis C virus polyprotein processing efficiency regulates infectious virus production TELLINGHUISEN, TIMOTHY SCRIPPS FLORIDA FL $85,215
Hepatitis - C 2017 NIAID 5R01AI065256-07 HIV Antiretroviral Therapy and Hepatic Injury SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $549,499
Hepatitis - C 2017 NIAID 5R01AI111970-04 Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models BROWN, ASHLEY UNIVERSITY OF FLORIDA FL $1,103,751
Hepatitis - C 2017 NIDA 5K01DA036452-04 Social Networks of Youth who Misuse Prescription Opioids and Risk for HIV/HCV AL-TAYYIB, ALIA DENVER HEALTH AND HOSPITAL AUTHORITY CO $151,618
Hepatitis - C 2017 NIAID 5R03AI119602-02 Identification of cellular factors that mediate HCV cell-to-cell spread UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $75,500
Hepatitis - C 2017 NIGMS 5P41GM103314-44 National Resource for Mass Spectrom of Biological Macromolecules CHAIT, BRIAN ROCKEFELLER UNIVERSITY NY $1,617,191
Hepatitis - C 2017 NIAID 5U19AI111825-04 7689 Effects of Persistent Innate Immune Activation on Vaccine Efficacy RICE, CHARLES ROCKEFELLER UNIVERSITY NY $599,480
Hepatitis - C 2017 NIDA 5R01DA039072-03 Life Course Investigation of People Who Inject Drugs BOOTH, ROBERT UNIVERSITY OF COLORADO DENVER CO $551,935
Hepatitis - C 2017 NIAID 5R01AI118916-02 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $507,805
Hepatitis - C 2017 NIDDK 5R01DK097374-05 Subversion of hepatocyte phosphoinositide metabolism by hepatitis C virus TAI, ANDREW UNIVERSITY OF MICHIGAN MI $338,213
Hepatitis - C 2017 NIDDK 1R01DK112295-01 Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV NAGGIE, SUSANNA DUKE UNIVERSITY NC $400,209
Hepatitis - C 2017 NIDDK 5R01DK101773-03 Innate Defense Program against HCV SAITO, TAKESHI UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis - C 2017 NIDA 5R01DA025885-09 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $543,284
Hepatitis - C 2017 NIDDK 1K01DK109025-01A1 MyD88-dependent B cell dysfunction and autoimmunity during chronic liver disease THAPA, MANOJ EMORY UNIVERSITY GA $102,281
Hepatitis - C 2017 NIDDK 5R01DK102883-03 HEPATOCYTE REMODELING BY HEPATITIS C VIRUS RANDALL, GLENN UNIVERSITY OF CHICAGO IL $350,489
Hepatitis - C 2017 NIAID 5R01AI085087-07 Role of Lipids in Hepatitis C Virus Maturation SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $387,500
Hepatitis - C 2017 NIAID 1R01AI120622-01A1 RESUBMISSION -R01 AI120622 –Restoration of Immunity and Function with DAA Treatment in HCV infection ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $388,750
Hepatitis - C 2017 NIDA 5K24DA035684-04 Treatment outcomes and comorbidity in HIV-infected IDU LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $165,901
Hepatitis - C 2017 NIDA 5R21DA041953-02 Modeling HCV/HIV transmission and Treatment as Prevention in U.S. Networks of People Who Inject Drugs ALTICE, FREDERICK YALE UNIVERSITY CT $258,852
Hepatitis - C 2017 NIAID 5U19AI123861-02 6292 Administrative Core LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $174,367
Hepatitis - C 2017 NIAID 5U19AI123861-02 6293 Antibody responses to HCV vaccine antigens in infection and vaccination LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $424,742
Hepatitis - C 2017 NIAID 5U19AI123861-02 6294 Novel HCV vaccine antigens targeting conserved neutralizing epitopes ZHU, JIANG SCRIPPS RESEARCH INSTITUTE CA $319,627
Hepatitis - C 2017 NCI 5R01CA186566-03 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $655,272
Hepatitis - C 2017 NINR 5F31NR016200-02 Nurse Case Management to Improve Hepatitis C Linkage to Care and Treatment in HIV Coinfection STARBIRD, LAURA JOHNS HOPKINS UNIVERSITY MD $36,559
Hepatitis - C 2017 NIGMS 5F31GM119345-02 Structure-based design of robust cross-genotypic NS3/4A protease inhibitors that avoid resistance MATTHEW, ASHLEY UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $31,207
Hepatitis - C 2017 NIAID 5R01AI120733-02 The Impact of HCV Infection on Bone Turnover, Density, and Strength BROWN, TODD JOHNS HOPKINS UNIVERSITY MD $762,061
Hepatitis - C 2017 NIAID 5U19AI088791-07 6463 Administrative Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $35,337
Hepatitis - C 2017 NIAID 5U19AI088791-07 6464 Scientific Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $266,709
Hepatitis - C 2017 NIAID 5U19AI088791-07 6465 Mechanisms driving breadth of HCV neutralization during repeated control of acute infection in humans BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $136,636
Hepatitis - C 2017 NIAID 5U19AI088791-07 6466 Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $161,104
Hepatitis - C 2017 NIAID 5U19AI088791-07 6467 Project 3: To define the genetic identity of infecting, superinfecting, and reinfecting strains of HCV and the dynamics of virus elimination, replacement or persistence SHAW, GEORGE UNIVERSITY OF PENNSYLVANIA PA $152,632
Hepatitis - C 2017 NIDDK 1F30DK112514-01 Hepatitis C virus cell entry host factor requirements and mechanisms CHAMBERS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $43,884
Hepatitis - C 2017 NIAID 5U19AI109662-04 7133 Haploid genetic screen to identify host genes required for RNA virruses GLENN, JEFFREY STANFORD UNIVERSITY CA $426,597
Hepatitis - C 2017 NIAID 5U19AI109662-04 7134 Computation and Repurposing to identfy antivirals directed against dominant PANDE, VIJAY STANFORD UNIVERSITY CA $722,109
Hepatitis - C 2017 NIDA 5P30DA040500-03 6227 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Admin Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $341,346
Hepatitis - C 2017 NIDA 5P30DA040500-03 6228 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Methodology Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $264,051
Hepatitis - C 2017 NIDA 5P30DA040500-03 6229 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) LINAS, BENJAMIN BOSTON MEDICAL CENTER MA $332,780
Hepatitis - C 2017 NIDA 5P30DA040500-03 6230 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Dissemination Core) MEISEL, ZACHARY UNIVERSITY OF PENNSYLVANIA PA $351,744
Hepatitis - C 2017 NIDA 5P30DA040500-03 6231 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Pilot Training Core) ADEN, BRANDON WEILL MEDICAL COLL OF CORNELL UNIV NY $77,061
Hepatitis - C 2017 NIAID 5R01AI071068-12 Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases KAY, MARK STANFORD UNIVERSITY CA $481,343
Hepatitis - C 2017 NIAID 5R01AI087925-07 Molecular determinants of hepatitis C virus assembly LINDENBACH, BRETT YALE UNIVERSITY CT $418,750
Hepatitis - C 2017 NIAID 5R01AI097552-04 Role of Lipid Droplets in Hepatitis C Virus Infection OTT, MELANIE J. DAVID GLADSTONE INSTITUTES CA $477,500
Hepatitis - C 2017 NCI 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $24,025
Hepatitis - C 2017 NIMHD 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $9,505
Hepatitis - C 2017 NHLBI 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $16,637
Hepatitis - C 2017 NIA 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $2,805
Hepatitis - C 2017 NIAID 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $104,911
Hepatitis - C 2017 NICHD 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $7,595
Hepatitis - C 2017 NIDA 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $11,871
Hepatitis - C 2017 NIDDK 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $6,364
Hepatitis - C 2017 NIGMS 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $6,364
Hepatitis - C 2017 NIDA 5R01DA033862-05 Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD HAVENS, JENNIFER UNIVERSITY OF KENTUCKY KY $555,961
Hepatitis - C 2017 NIDDK 5R01DK109823-02 HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression TIEN, PHYLLIS NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $692,364
Hepatitis - C 2017 NIDA 5U01DA036267-05 MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) GORBACH, PAMINA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $1,488,949
Hepatitis - C 2017 NIGMS 5R01GM105414-05 Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV BLACKARD, JASON UNIVERSITY OF CINCINNATI OH $299,434
Hepatitis - C 2017 NCI 5U01AI069918-12 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $502,095
Hepatitis - C 2017 NIAID 5U01AI069918-12 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $2,240,694
Hepatitis - C 2017 NIDA 5U01AI069918-12 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $299,953
Hepatitis - C 2017 NIDA 5R01DA036514-04 Evaluating a Microfinance Intervention for High Risk Women in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $664,795
Hepatitis - C 2017 NCATS 5KL2TR001441-03 UTMB Clinical and Translational Science Award AMEREDES, BILL UNIVERSITY OF TEXAS MED BR GALVESTON TX $313,812
Hepatitis - C 2017 NIDA 1R01DA043409-01 Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention HERBECK, JOSHUA UNIVERSITY OF WASHINGTON WA $668,778
Hepatitis - C 2017 NIAID 1R21AI124923-01A1 Immune correlates of HAART-mediated spontaneous control of chronic HCV infection OSBURN, WILLIAM JOHNS HOPKINS UNIVERSITY MD $245,282
Hepatitis - C 2017 NIDA 5R01DA026770-08 Early-Stage Chronic Kidney Disease in HIV-infected Individuals LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $620,459
Hepatitis - C 2017 NIDA 1R03DA041892-01A1 Migrant Puerto Rican PWID: The Influence of Acculturation and Enculturation on HIV and HCV Risk Behaviors GELPI-ACOSTA, CAMILA NATIONAL DEVELOPMENT & RES INSTITUTES NY $159,932
Hepatitis - C 2017 NHLBI 1K23HL133358-01A1 Elucidating Hepatitis C Infection as a Risk Factor for Coronary Heart Disease in HIV-Infected Patients BAGCHI, SHASHWATEE UNIVERSITY OF MARYLAND BALTIMORE MD $182,354
Hepatitis - C 2017 NIDA 5R37DA013806-18 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $733,577
Hepatitis - C 2017 NIDDK 5R01DK106244-02 Hepatitus C virus-induced inflammasome and lipid metabolism WARIS, GULAM ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $351,000
Hepatitis - C 2017 NHGRI 5RM1HG009038-02 Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease GELLER, GAIL JOHNS HOPKINS UNIVERSITY MD $1,027,331
Hepatitis - C 2017 NIMH 5R01MH085538-08 Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients PULLIAM, LYNN NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $486,540
Hepatitis - C 2017 NIDA 5R34DA039333-03 Hepatitis C Treatment As Prevention Pilot Study with Ledipasvir-Sofosbuvir Among People Actively Injecting Drugs (TasP-C Pilot) COFFIN, PHILLIP PUBLIC HEALTH FOUNDATION ENTERPRISES CA $114,015
Hepatitis - C 2017 NIDA 5R01DA040499-03 Antiviral pharmacology and adherence in drug users KISER, JENNIFER UNIVERSITY OF COLORADO DENVER CO $521,567
Hepatitis - C 2017 NIMHD 5U01MD010614-02 Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities CARRASQUILLO, OLVEEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $487,186
Hepatitis - C 2017 NIDA 5K02DA035116-05 Social Networks and HIV Risk Behaviors of Special Populations of Drug Users OSER, CARRIE UNIVERSITY OF KENTUCKY KY $115,827
Hepatitis - C 2017 NIDA 5R01DA022177-11 Opioids, HIV/HCV and host cell innate immunity HO, WENZHE TEMPLE UNIV OF THE COMMONWEALTH PA $271,250
Hepatitis - C 2017 OD 5R01OD011095-25 Modeling Viral and T Lymphocyte Dynamics PERELSON, ALAN LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $444,412
Hepatitis - C 2017 NIAAA 5R01AA021133-05 RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse PROESCHOLD-BELL, RAE JEAN DUKE UNIVERSITY NC $742,809
Hepatitis - C 2017 NIAID 5K23AI108355-03 Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients VENUTO, CHARLES UNIVERSITY OF ROCHESTER NY $149,818
Hepatitis - C 2017 NIAID 5U19AI082630-09 7590 Restoration of Innate Immunity with Viral Cure CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $480,820
Hepatitis - C 2017 NIAID 5U19AI082630-09 7591 Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $483,362
Hepatitis - C 2017 NIAID 5U19AI082630-09 7592 Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy HAINING, WILLIAM DANA-FARBER CANCER INST MA $410,216
Hepatitis - C 2017 NIAID 5U19AI082630-09 7593 Induction and Recovery of T Cells after Cure of Chronic Viral Infection KLENERMAN, PAUL UNIVERSITY OF OXFORD UK $248,236
Hepatitis - C 2017 NIAID 5U19AI082630-09 7594 Administrative Core CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $172,929
Hepatitis - C 2017 NIAID 5U19AI082630-09 7595 Pilot/Feasibility Studies Program CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $86,386
Hepatitis - C 2017 NIAID 5U19AI082630-09 7596 Tissue and Clinical Core KIM, ARTHUR MASSACHUSETTS GENERAL HOSPITAL MA $287,509
Hepatitis - C 2017 NIAID 5U19AI082630-09 7597 Virology Core ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $107,652
Hepatitis - C 2017 NIAID 5R01AI125416-02 Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle HORNER, STACY DUKE UNIVERSITY NC $509,609
Hepatitis - C 2017 NIDA 5R01DA039775-03 Impact of HCV Therapy on CNS Outcomes BHARTI, AJAY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $693,763
Hepatitis - C 2017 NHLBI 5R01HL126543-05 Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms KAPLAN, ROBERT ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $811,852
Hepatitis - C 2017 NIAID 5R01AI079031-09 Understanding human neutralizing antibodies to hepatitis C virus LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $556,005
Hepatitis - C 2017 NIDA 5R01DA040449-03 Impact on opioid use of bundling medication-assisted treatment with mHealth GUSTAFSON, DAVID UNIVERSITY OF WISCONSIN-MADISON WI $699,519
Hepatitis - C 2017 NIDA 5R01DA037440-06 Reducing Hazardous Alcohol Use & HIV Viral Load:An RCT in ART Clinics in Vietnam GO, VIVIAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $428,537
Hepatitis - C 2017 NIAID 5R21AI126304-02 Hepacivirus control by T cells and broadly active antibodies MEALEY, ROBERT WASHINGTON STATE UNIVERSITY WA $228,000
Hepatitis - C 2017 NIDA 5R01DA041501-02 The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $746,948
Hepatitis - C 2017 NIDA 5R01DA037117-04 Injection Risk Networks in Rural Puerto Rico DOMBROWSKI, KIRK UNIVERSITY OF NEBRASKA LINCOLN NE $558,609
Hepatitis - C 2017 NCI 1R21CA209940-01A1 Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma POCHET, NATHALIE BRIGHAM AND WOMEN'S HOSPITAL MA $227,331
Hepatitis - C 2017 NIAID 5R01AI107301-05 Genetic viral and host adaptations to breach species barriers of HCV PLOSS, ALEXANDER PRINCETON UNIVERSITY NJ $402,500
Hepatitis - C 2017 NIGMS 5U01GM110749-05 Modeling Epidemic Infectious Diseases Using Sequence Analysis POND, SERGEI TEMPLE UNIV OF THE COMMONWEALTH PA $577,689
Hepatitis - C 2017 NIAID 1R01AI125365-01A1 Analyses of the Antiviral and Antifibrotic Mechanisms of Action of NS5A and Cyclophilin Inhibitors GALLAY, PHILIPPE SCRIPPS RESEARCH INSTITUTE CA $481,250
Hepatitis - C 2017 NIAID 5K01AI122853-03 Optimizing Care for HIV/HCV-Coinfected Patients in the New HCV Treatment Era MARCUS, JULIA HARVARD PILGRIM HEALTH CARE, INC. MA $145,520
Hepatitis - C 2017 NIDA 5K24DA037034-04 Mentoring and Empowerment in the Context of HIV Care for At-Risk Populations JOHNSON, MALLORY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $183,707
Hepatitis - C 2017 NIAID 5R01AI126890-02 T cell Immunity and the Outcome of Acute HCV Infection WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $758,458
Hepatitis - C 2017 NIAID 5F32AI126892-02 The role of epistatic networks in shaping adaptive landscapes ACEVEDO, ASHLEY ROCKEFELLER UNIVERSITY NY $57,066
Hepatitis - C 2017 NIAID 5K24AI108516-05 HIV, HCV, and gender effects on Liver, Bone, and Vascular Health TIEN, PHYLLIS UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $134,092
Hepatitis - C 2017 NIAID 5R01AI108403-05 Antibody-Mediated Suppression of Antiviral Inflammasome Activation COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $442,767
Hepatitis - C 2017 NIAID 5R21AI126582-02 Structure-based HCV vaccine design FOUNG, STEVEN STANFORD UNIVERSITY CA $193,150
Hepatitis - C 2017 NIDA 5R21DA042727-02 Novel methods for research on young rural opioid users at risk of HIV, HCV & OD COOPER, HANNAH EMORY UNIVERSITY GA $192,742
Hepatitis - C 2017 NCI 5R01CA206465-02 (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer JUSTICE, AMY YALE UNIVERSITY CT $527,068
Hepatitis - C 2017 NIAAA 5R01AA023726-04 Comparing Brief Alcohol Interventions for HIV-HCV Co-infected Persons STEIN, MICHAEL BUTLER HOSPITAL (PROVIDENCE, RI) RI $486,205
Hepatitis - C 2017 NIAID 5R21AI124100-02 Defining novel Riplet-activated antiviral innate immune signaling pathways HORNER, STACY DUKE UNIVERSITY NC $198,750
Hepatitis - C 2017 NIAAA 1R01AA025204-01A1 NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis - C 2017 NIAID 5R01AI105007-04 Cyclophilins and the IFN Response GALLAY, PHILIPPE SCRIPPS RESEARCH INSTITUTE CA $401,255
Hepatitis - C 2017 NIDA 5K23DA041294-02 The impact of social networks on hepatitis C transmission and care access in people who inject drugs FALADE-NWULIA, OLUWASEUN JOHNS HOPKINS UNIVERSITY MD $183,748
Hepatitis - C 2017 NIDDK 1K23DK109294-01A1 Factors Responsible for Liver Recovery After Successful Treatment of Hepatitis C. DUNN, WINSTON UNIVERSITY OF KANSAS MEDICAL CENTER KS $201,300
Hepatitis - C 2017 NIAID 5F32AI126660-02 RNA-Protein Interactions During Hepatitis C Virus Infection ADAMS, REBECCA YALE UNIVERSITY CT $57,066
Hepatitis - C 2017 NIDA 5R13DA040427-03 Dissemination and implementation of evidenced based treatments for substance abuse disorders and HIV for justice involved populations FERGUSON, WARREN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $25,511
Hepatitis - C 2017 NIDDK 1R21DK108045-01A1 Waiting List and Kidney Transplant Outcomes for Patients with Hepatitis C Infection REESE, PETER UNIVERSITY OF PENNSYLVANIA PA $258,179
Hepatitis - C 2017 NIAAA 5K24AA022523-05 Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis KHALILI, MANDANA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $180,062
Hepatitis - C 2017 NIDA 5R01DA013324-19 HIV and Hepatitis C Pathogenesis & The Human Genome THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $720,712
Hepatitis - C 2017 NIDA 5R01DA040506-03 A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (the REACT Study) MATTHEWS, GAIL UNIVERSITY OF NEW SOUTH WALES AUSTRA $1,072,560
Hepatitis - C 2017 NIDA 5K01DA037802-04 Understanding the interpersonal context of HIV/HCV risk within injecting dyads MORRIS, MEGHAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $182,698
Hepatitis - C 2017 NIDA 5R01DA016017-15 Acute Hepatitis C Infection in Young Injectors PAGE, KIMBERLY UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $1,358,160
Hepatitis - C 2017 NIGMS 5R35GM119634-02 Understanding Evolution of Protein Function Through Design. KORENDOVYCH, IVAN SYRACUSE UNIVERSITY NY $361,000
Hepatitis - C 2017 NIDDK 1R01DK113645-01 Hepatitis C virus infection and mechanism of liver disease progression RAY, RANJIT SAINT LOUIS UNIVERSITY MO $340,875
Hepatitis - C 2017 NIDDK 5R01DK088787-07 HCV Entry: Mechanisms and Therapeutics WANG, TONY SRI INTERNATIONAL CA $597,258
Hepatitis - C 2017 NIDDK 2R01DK094652-06A1 Hepatitis C virus and autophagic response OU, J.-H. JAMES UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis - C 2017 NIAAA 5R37AA014372-15 HCV, Alcohol and Host Defense SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $367,110
Hepatitis - C 2017 NIDA 5K23DA039060-03 Adaptation and testing of a primary care HCV group medical treatment intervention NORTON, BRIANNA ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $184,352
Hepatitis - C 2017 NIAID 1R01AI131518-01 Hepatitis C virus genome structure: dynamic roles in replication and infectivity PYLE, ANNA YALE UNIVERSITY CT $592,104
Hepatitis - C 2017 NIAID 1R01AI127469-01A1 Molecular and structural characterization of broadly neutralizing anti-HCV antibodies BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $744,817
Hepatitis - C 2017 NIAID 1R13AI131602-01 Modeling Viral Infections and Immunity PETERSON, JANE KEYSTONE SYMPOSIA CO $12,500
Hepatitis - C 2017 NIDA 1R34DA043957-01 Preventing Injection: An mHealth intervention that leverages social networks to prevent progression to injection among young opioid users ACOSTA, MICHELLE NATIONAL DEVELOPMENT & RES INSTITUTES NY $268,625
Hepatitis - C 2017 NIAID 1R01AI131688-01 Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection RICE, CHARLES ROCKEFELLER UNIVERSITY NY $703,869
Hepatitis - C 2017 FIC 5U54CA190165-04 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $15,443
Hepatitis - C 2017 NCI 5U54CA190165-04 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $207,321
Hepatitis - C 2017 NIDA 5R01DA041736-02 Individual, Network and Spatial Drivers of HIV and HCV among PWID in India SOLOMON, SUNIL JOHNS HOPKINS UNIVERSITY MD $963,776
Hepatitis - C 2017 NIAID 5U01AI131314-02 Immune Control and Evadion during Acute HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $276,000
Hepatitis - C 2017 NIDDK 5R01DK108364-03 HIV and hepatic inflammation and fibrosis BANSAL, MEENA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $212,000
Hepatitis - C 2017 NIDDK 5R01DK108362-03 Hepatitis E in HIV-Infected Patients SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $274,999
Hepatitis - C 2017 NIAAA 5U01AA020799-07 4/6 COMpAAAS U01: Operations Research Study BRAITHWAITE, RONALD NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $197,206
Hepatitis - C 2017 NIAAA 5U01AA020790-07 2/6 COMpAAAS U01: Observation Study JUSTICE, AMY YALE UNIVERSITY CT $1,006,227
Hepatitis - C 2017 NIDA 5R01DA043130-02 A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs METSCH, LISA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $1,628,816
Hepatitis - C 2017 NIDA 5R01DA041298-02 Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $571,298
Hepatitis - C 2017 NIDA 1T32DA041898-01A1 Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE) DRAINONI, MARI-LYNN BOSTON UNIVERSITY MEDICAL CAMPUS MA $160,739
Hepatitis - C 2017 NIAID 5U01AI131313-02 T Cell Immunity and HCV Infection Outcome WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $275,514
Hepatitis - C 2017 NIAAA 5U24AA020794-07 1/6 COMpAAAS U24: Coordinating Center JUSTICE, AMY YALE UNIVERSITY CT $235,620
Hepatitis - C 2017 NIDDK 1R43DK112540-01A1 Next generation quantitative HCV drug resistance assay WAGNER, RICHARD MEDOSOME BIOTEC, LLC IN $232,433
Hepatitis - C 2017 NIDDK 5R01DK108370-03 HIV-Associated Macrophage Alterations and Progressive Liver Disease CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $325,000
Hepatitis - C 2017 NIDDK 1R01DK110024-01A1 Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis ROBERTSON, KEITH MAYO CLINIC ROCHESTER MN $620,487
Hepatitis - C 2017 NIDDK 5K23DK101827-03 Bacterial Translocation and the Intestinal Microbiome in Recurrent Disease Following Liver Transplantation VERNA, ELIZABETH COLUMBIA UNIVERSITY HEALTH SCIENCES NY $167,724
Hepatitis - C 2017 OD 1R01DA044135-01 Regulatory T cell dysfunction in HIV-1/HCV drug users LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $198,575
Hepatitis - C 2017 OD 1R01AA025882-01 Computer-based Alcohol Reduction Intervention for alcohol-using HIV/HCV+ Russian women in Clinical Care DICLEMENTE, RALPH EMORY UNIVERSITY GA $187,617
Hepatitis - C 2017 NIDA 1R01DA044111-01 Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women KOVACS, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $731,445
Hepatitis - C 2017 NICHD 5R21HD089457-02 A Phase 1 Pharmacokinetic Trial of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination in Pregnant Women with Chronic Hepatitis C Virus Infection CHAPPELL, CATHERINE MAGEE-WOMEN'S RES INST AND FOUNDATION PA $161,520
Hepatitis - C 2017 NIAID 5R01AI123136-02 Flavivirus non-coding RNAs and the Host mRNA Decay Machinery WILUSZ, JEFFREY COLORADO STATE UNIVERSITY CO $372,709
Hepatitis - C 2017 NIAID 5U19AI123862-02 6263 Project 2 - France BAUMERT, THOMAS STANFORD UNIVERSITY CA $235,412
Hepatitis - C 2017 NIAID 5U19AI123862-02 6262 Humoral immunity against hepatitis C in protected subjects FOUNG, STEVEN STANFORD UNIVERSITY CA $470,243
Hepatitis - C 2017 NIAID 5U19AI123862-02 6261 Admin Core FOUNG, STEVEN STANFORD UNIVERSITY CA $46,591
Hepatitis - C 2017 NIAID 1R01AI132213-01 Structure-Based Vaccine Design for Hepatits C Virus FUERST, THOMAS UNIV OF MARYLAND, COLLEGE PARK MD $1,449,630
Hepatitis - C 2017 NIAID 5F31AI126863-02 Host and viral determinants of hepatitis C virus species tropism GRAY, ESSANNA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $39,264
Hepatitis - C 2017 NIGMS 1R01GM121600-01A1 Computational discovery of effective hepatitis C intervention strategies DAHARI, HAREL LOYOLA UNIVERSITY CHICAGO IL $423,260
Hepatitis - C 2017 NIDA 1K99DA043011-01A1 Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE Trial AKIYAMA, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $184,734
Hepatitis - C 2017 NIAID 3F32AI126660-01S1 RNA-Protein Interactions During Hepatitis C Virus Infection ADAMS, REBECCA YALE UNIVERSITY CT $1,600
Hepatitis - C 2017 NIDA 1R01DA043484-01A1 Contextual risk factors for hepatitis C among young persons who inject drugs BOODRAM, BASMATTEE UNIVERSITY OF ILLINOIS AT CHICAGO IL $539,772
Hepatitis - C 2017 NIAID 1R13AI133971-01 The 24th International Symposium on Hepatitis C Virus and Related Viruses LINDENBACH, BRETT YALE UNIVERSITY CT $5,000
Hepatitis - C 2017 NIDA 1R21DA044807-01 Examining the social, spatial, and temporal context of injection drug use and HIV and HCV risk among people who inject drugs in Ukraine OWCZARZAK, JILL JOHNS HOPKINS UNIVERSITY MD $245,250
Hepatitis - C 2017 NIAAA 1U01AA026209-01 1/3 Collaborative Research in HIV/AIDS, Alcohol, and Related Comorbidities (COMpAAAS) Tripartite: ART-CC, KP, and VA MAY, MARGARET UNIVERSITY OF BRISTOL UK $456,829
Hepatitis - C 2017 NIAAA 1U01AA026224-01 3/3 COMpAAAS Tripartite: ART-CC, KP, and VA JUSTICE, AMY YALE UNIVERSITY CT $587,980
Hepatitis - C 2017 NIAAA 1U01AA026230-01 2/3 COMpAAAS Tripartite: ART-CC, KP, and VA SILVERBERG, MICHAEL KAISER FOUNDATION RESEARCH INSTITUTE CA $607,613
Hepatitis - C 2017 NIAID 2R56AI080703-06A1 Hepatitits C Virus Trafficking in Infected Hepatocytes RANDALL, GLENN UNIVERSITY OF CHICAGO IL $397,545
Hepatitis - C 2017 NIDA 1R01DA043396-01A1 Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs KOTTILIL, SHYAMASUNDARAN UNIVERSITY OF MARYLAND BALTIMORE MD $367,177
Hepatitis - C 2017 NIDA 1UG3DA044798-01 Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE) YOUNG, APRIL UNIVERSITY OF KENTUCKY KY $218,958
Hepatitis - C 2017 NIDA 1U24DA044801-01 Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $623,509
Hepatitis - C 2017 NIDA 1UG3DA044822-01 Implementing a Community-Based Response to the Opioid Epidemic in Rural Ohio MILLER, WILLIAM OHIO STATE UNIVERSITY OH $591,750
Hepatitis - C 2017 NIDA 1UG3DA044823-01 Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern Appalachia ZULE, WILLIAM RESEARCH TRIANGLE INSTITUTE NC $564,366
Hepatitis - C 2017 NIDA 1UG3DA044825-01 Rural West Virginia Responds to Opioid Injection Epidemics: From Data to Action FEINBERG, JUDITH WEST VIRGINIA UNIVERSITY WV $150,031
Hepatitis - C 2017 NIDA 1UG3DA044826-01 Community-based, client-centered prevention homes to address the rural opioid epidemic WESTERGAARD, RYAN UNIVERSITY OF WISCONSIN-MADISON WI $621,231
Hepatitis - C 2017 NIDA 1UG3DA044829-01 Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC) PHO, MAI UNIVERSITY OF CHICAGO IL $589,199
Hepatitis - C 2017 NIDA 1UG3DA044830-01 Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE) FRIEDMANN, PETER BAYSTATE MEDICAL CENTER MA $663,202
Hepatitis - C 2017 NIDA 1UG3DA044831-01 Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study KORTHUIS, PHILIP OREGON HEALTH & SCIENCE UNIVERSITY OR $493,678
Hepatitis - C 2017 NIAID N01AI40074-32-0-3 Sexually Transmitted Infections Clinical Trials Group LINDA, GIUDICE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $2,564,303
Hepatitis - C 2017 NHLBI 1R21HL140269-01 Origin and evolution of virome in development of post-transfusion hepatitis KAPOOR, AMIT RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $113,625
Hepatitis - C 2017 NCI 3P30AI042853-19S1 7424 Clinical Sciences Core BECKWITH, CURT MIRIAM HOSPITAL RI $11,721
Hepatitis - C 2017 NHLBI 3P30AI042853-19S1 7424 Clinical Sciences Core BECKWITH, CURT MIRIAM HOSPITAL RI $9,741
Hepatitis - C 2017 NIA 3P30AI042853-19S1 7424 Clinical Sciences Core BECKWITH, CURT MIRIAM HOSPITAL RI $954
Hepatitis - C 2017 NIAID 3P30AI042853-19S1 7424 Clinical Sciences Core BECKWITH, CURT MIRIAM HOSPITAL RI $55,341
Hepatitis - C 2017 NICHD 3P30AI042853-19S1 7424 Clinical Sciences Core BECKWITH, CURT MIRIAM HOSPITAL RI $4,434
Hepatitis - C 2017 NIDA 3P30AI042853-19S1 7424 Clinical Sciences Core BECKWITH, CURT MIRIAM HOSPITAL RI $7,319
Hepatitis - C 2017 NIAID 1R56AI126995-01A1 Role of macrophage activation in HBV/HIV co-infection-induced liver disease BILITY, MOSES UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $387,813
Hepatitis - C 2017 NCI 3R01CA186566-03S1 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $113,799
Hepatitis - C 2017 NHLBI AHL15003001-1-0-1 Temporal Trends in Transfusion –Transmissible Infections Risks and Monitoring of Donor Risk Factors in the US Blood Supply Project (TTIMS) NO PI IDENTIFIED NIH $357,328
Hepatitis - C 2017 NHLBI AHL16005001-1-0-1 Temporal Trends in Transfusion –Transmissible Infections Risks and Monitoring of Donor Risk Factors in the US Blood Supply Project (TTIMS)-Non-AIDS NO PI IDENTIFIED NIH $231,000
Hepatitis - C 2017 NIDA 1R21DA044251-01A1 Examining Social Influences on Syringe Exchange Uptake among Rural PWID at Risk for HIV SURRATT, HILARY UNIVERSITY OF KENTUCKY KY $230,609
Hepatitis - C 2017 NHGRI 3RM1HG009038-02S1 Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease GELLER, GAIL JOHNS HOPKINS UNIVERSITY MD $64,177
Hepatitis - C 2017 OD 3U01DA040381-02S1 Cohort Studies on HIV/AIDS and Substance Abuse in Miami BAUM, MARIANNA FLORIDA INTERNATIONAL UNIVERSITY FL $166,800
Hepatitis - C 2017 NIDA 1R01DA045713-01 A Multi-site Multi-Setting RCT of Integrated HIV Prevention and HCV Care for PWID METSCH, LISA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $1,322,957
Hepatitis - C 2017 NIDA 3P30DA040500-03S1 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $99,998
Hepatitis - C 2017 NCI 261201200042I-2-26100007-1 CONTRACTOR: MAYO CLINIC; DUNNS: 006471700; PILOT STUDY OF EGFR INHIBITION WITH ERLOTINIB IN CIRRHOSIS TO INHIBIT FIRBROGENESIS AND PREVENT HEPATOCELLULAR CARCINOMA HHSN261201200042I; TASK ORDER HHSN26 LIMBURG, PAUL MAYO CLINIC ROCHESTER MN $96,186
Hepatitis - C 2017 NCI 261201200042I-4-26100006-1 CONTRACTOR: MAYO CLINIC; DUNNS: 006471700; PHASEI/II TRIAL OF A THERAPEUTIC DNA VACCINE FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION;HHSN261201200042I; TASK ORDER HHSN26100006; 09/09/2014 09/08/2016 LIMBURG, PAUL MAYO CLINIC ROCHESTER MN $86,842
Hepatitis - C 2017 NIMHD 3U01MD010614-02S1 Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities CARRASQUILLO, OLVEEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $74,409
Hepatitis - C 2017 NIDA 3R01DA033862-05S1 Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD HAVENS, JENNIFER UNIVERSITY OF KENTUCKY KY $275,701
Hepatitis - C 2017 NIAID 1R56AI126493-01A1 The role of HCV RNA-targeted phosphatase PTPRE in T cell activation STAPLETON, JACK UNIVERSITY OF IOWA IA $538,304
Hepatitis - C 2017 NIAID 272201400058C-7-0-1 Discovery and Characterization of B-Cell Epitopes for Hepatitis C Virus and Ebola Virus DORANZ, BENJAMIN INTEGRAL MOLECULAR PA $674,441
Hepatitis - C 2017 NIAID 3F32AI126892-01S1 The role of epistatic networks in shaping adaptive landscapes ACEVEDO, ASHLEY ROCKEFELLER UNIVERSITY NY $1,400
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer